Zydus Lifesciences Share Price
1131.50-11.50 (-1.01%)
+12.23% past 1 Year
News
Zydus Lifesciences reports positive Phase II(b) MASH trial outcome
Equity
ZYDUSLIFE
Zydus Lifesciences sees Rs 24.58 crores NSE block trade at Rs 1173.20
Equity
ZYDUSLIFE
Macquarie maintains Outperform on Zydus Life with Rs 1,285 target
Equity
ZYDUSLIFE
Zydus Lifesciences forms IFSC treasury subsidiary in GIFT City Gandhinagar
Equity
ZYDUSLIFE
Zydus Lifesciences gets final USFDA nod for Ascorbic Acid injection
Equity
ZYDUSLIFE
Hearing bars Zydus Life from launching Novartis linked dabrafenib drug
Equity
ZYDUSLIFE
Citi maintains Sell on Zydus Lifesciences with Rs 1,040 target
Equity
ZYDUSLIFE
CLSA Maintains Outperform On Zydus Lifesciences With Rs 1,310 Target
Equity
ZYDUSLIFE
HSBC keeps Hold on Zydus Lifesciences with Rs 1,100 target price
Equity
ZYDUSLIFE
Jefferies reiterates Buy on Zydus with Rs 1,370 target price
Equity
ZYDUSLIFE
Zydus Life flags quarterly uplift from Assertio Holdings addition
Equity
ZYDUSLIFE
Zydus Life sees branded portfolio driving most revenue, US share to rise
Equity
ZYDUSLIFE
Zydus Life expects strong FY27 revenue growth with India led expansion
Equity
ZYDUSLIFE
Zydus Life keeps FY27 EBITDA margin target above 24 percent
Equity
ZYDUSLIFE
Zydus Lifesciences Q1 EBITDA falls, margin contracts sharply year on year
Equity
ZYDUSLIFE
Zydus Lifesciences reports higher Q1 revenue at Rs 8,000 crores
Equity
ZYDUSLIFE
Zydus Lifesciences Q1 net profit falls below estimates on yearly basis
Equity
ZYDUSLIFE
Zydus Life gets USFDA final nod, 180-day CGT exclusivity boost
Equity
ZYDUSLIFE
Zydus Lifesciences receives USFDA EIR for injectable manufacturing facility
Equity
ZYDUSLIFE
Zydus Lifesciences gets approval for Phase III desidustat sickle cell trial
Equity
ZYDUSLIFE